Maastricht Science Programme, Faculty of Science and Engineering, Maastricht University, Kapoenstraat 2, PO Box 616, 6200, MD, Maastricht, the Netherlands.
Institut für Anorganische Chemie, Technische Universität Graz, Stremayrgasse 9, A-8010, Graz, Austria.
Eur J Med Chem. 2020 Sep 1;201:112483. doi: 10.1016/j.ejmech.2020.112483. Epub 2020 May 28.
While many examples of osmium complexes, as anti-cancer agents, have been reported and some reviews have been devoted to this topic, a particularly interesting and synthetically accessible sub-class of these compounds namely those bearing a π- bound arene and phosphane co-ligand have escaped review. These complexes have made a surprisingly late entry in the literature (2005) in terms of anti-cancer investigations. This is somewhat surprising considering the plethora of analogous complexes that have been reported for the lighter analogue, ruthenium. Herein we review all complexes, neutral and ionic, bearing the "(ƞ-arene)Os(PR)" moiety focusing on their synthesis, reactivity, structural features (by X-ray diffraction analysis) as well as anti-cancer biological activity. An attempt is made throughout the article to contrast these to each other and to analogous Ru systems, and a full summary of all existing in vitro biological data is presented.
虽然已经有许多作为抗癌剂的锇配合物的例子被报道,并且有些综述也专门讨论了这个主题,但这些化合物中一个特别有趣且具有合成可及性的亚类,即那些具有π键结合的芳烃和膦共配体的化合物,却没有被综述。这些配合物在抗癌研究方面的文献中出现得非常晚(2005 年)。考虑到已经报道了大量类似的配合物用于较轻的类似物钌,这有点令人惊讶。在这里,我们综述了所有带有“(ƞ-芳烃)Os(PR)”部分的中性和离子配合物,重点关注它们的合成、反应性、结构特征(通过 X 射线衍射分析)以及抗癌生物活性。本文试图将它们彼此之间以及与类似的 Ru 体系进行对比,并全面总结了所有现有的体外生物学数据。